A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions ABSORB III

  • Kotter, John (PI)
  • Abdel-Latif, Ahmed (Former PI)
  • Ziada, Khaled (Former PI)

Grants and Contracts Details

StatusActive
Effective start/end date8/27/134/24/23

Funding

  • Abbott Vascular: $378,775.00